Trials / Conditions / ERBB2 Mutation-Related Tumors
ERBB2 Mutation-Related Tumors
3 registered clinical trials studyying ERBB2 Mutation-Related Tumors — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance NCT07122882 | Chang Gung Memorial Hospital | — |
| Not Yet Recruiting | RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations NCT06185400 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Unknown | Disitamab Vedotin Combined Therapy for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations NCT05847764 | Sun Yat-sen University | Phase 2 |